Hansoh Pharmaceutical Group Company Stock

HKD29.10

0.68% yesterday

Hong Kong, Jun 26, 10:08 am CET

ISIN

KYG549581067

Symbol

3692

Index

Hang Seng

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts Strategies

Hansoh Pharmaceutical Group Company Stock price

HKD29.10

-8.10 21.77% 5Y

Hong Kong, Closing price Thu, Jun 26 2025

-0.20 0.68%

ISIN

KYG549581067

Symbol

3692

Index

Hang Seng

Sector

Health

Industry

Pharmaceuticals

Key metrics

Basic

Market capitalization

HKD174.3b

Enterprise Value

HKD148.8b

Net debt

HKD-25.5b

Cash

HKD25.6b

Shares outstanding

5.9b

Valuation (TTM | estimate)

P/E

36.63 | 34.29

P/S

12.99 | 11.67

EV/Sales

11.10 | 9.97

EV/FCF

39.77

P/B

5.54

Dividends

DPS

HKD0.34

Yield 1Y | 5Y

1.17% | 0.60%

Growth 1Y | 5Y

184.34% | -

Payout 1Y | 3Y

57.20% | 38.71%

Increased

1 Year

Financials (TTM | estimate)

Revenue

HKD13.4b | HKD14.9b

EBITDA

HKD4.8b | HKD5.6b

EBIT

HKD4.4b

Net Income

HKD4.8b | HKD5.1b

Free Cash Flow

HKD3.7b

Growth (TTM | estimate)

Revenue

21.35% | 11.34%

EBITDA

44.42% | 16.51%

EBIT

49.20%

Net Income

33.39% | 6.06%

Free Cash Flow

18.08%

Margin (TTM | estimate)

Gross

90.89%

EBITDA

35.85% | 37.47%

EBIT

32.58%

Net

35.66% | 33.96%

Free Cash Flow

27.90%

EPS

HKD0.80

FCF per Share

HKD0.63

Short interest

Employees

8.99k

Rev per Employee

HKD1.49m

As a Free StocksGuide user, you can view scores for all 6,912 stocks worldwide.

Get Started for Free Today

Hansoh Pharmaceutical Group Company Stock Analysis

Unlock Scores for Free

??

28 Analysts have issued a Hansoh Pharmaceutical Group Company forecast:

27x Buy

96%

More details on Analyst Estimates Including Price Targets

28 Analysts have issued a Hansoh Pharmaceutical Group Company forecast:

Buy

96%

Hold

Analyst Estimates with Stock Price Targets

Financial data from Hansoh Pharmaceutical Group Company

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Dec '24		+/- %
Revenue	13,428 13,428	21% 21% 100%
- Direct Costs	1,223 1,223	8% 8% 9%
Gross Profit	12,205 12,205	23% 23% 91%
- Selling and Administrative Expenses	4,918 4,918	5% 5% 37%
- Research and Development Expense	2,959 2,959	29% 29% 22%
EBITDA	4,814 4,814	44% 44% 36%
- Depreciation and Amortization	440 440	10% 10% 3%
EBIT (Operating Income) EBIT	4,375 4,375	49% 49% 33%
Net Profit	4,788 4,788	33% 33% 36%

In millions HKD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Company Profile

Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. Its products include oncology, anti-infective, anti-diabetic, gastrointestinal, and cardiovascular drugs. The company was founded by Huijuan Zhong on December 2, 2015 and is headquartered in Lianyungang, China.

Head office	Cayman Islands
CEO	Hui Zhong
Employees	8,989
Founded	2015
Website	www.hspharm.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now